|
WO2015158270A1
|
|
Exenatide-containing composition and preparation method therefor
|
|
CN104666291A
|
|
Application of O-desmethylvenlafaxine benzoate compound in preparation of medicines for improving sexual dysfunction
|
|
CN104188924A
|
|
Pantoprazole sodium medicine composition for injection
|
|
CN105342999A
|
|
Exenatide oral nanoparticle
|
|
CN104127401A
|
|
Osmotic pump control-released composition containing desmethylvenlafaxine benzoate compound
|
|
CN105310974A
|
|
Implant of rotigotine and derivatives or pharmaceutical salts thereof
|
|
CN105277606A
|
|
Determination method for exenatide related substance
|
|
CN103932992A
|
|
Exenatide-containing composition
|
|
CN103932993A
|
|
Composition containing exenatide or salts and analogues of exenatide
|
|
CN103784532A
|
|
Antirheumatic liquid composition and preparation method thereof
|
|
CN104672097A
|
|
Preparation method and application of p-toluylic acid 4-(2-dimethylamino-1-cyclohexenyl ethyl) phenyl ester compound
|
|
CN103808665A
|
|
Method for determining content of multi-index components in purification process of Chinese buckeye seed extractive
|
|
CN104458929A
|
|
Composition of gonadotropic hormone releasing hormone analogue
|
|
CN103172555A
|
|
Indole alkaloid compound separated from rhizoma cimicifugae as well as preparation method and application thereof
|
|
CN103203123A
|
|
Automatic judgment and control for eluant receiving of buckeye extract
|
|
CN103127007A
|
|
Sodium glycididazole composition and preparation method thereof
|
|
CN103110933A
|
|
Elcatonin composition and preparation method thereof
|
|
CN103191021A
|
|
Equipment for continuously producing microspheres and application of equipment
|
|
CN103863984A
|
|
Sterile filling infusion system with automatic liquid feeding control
|
|
CN103120644A
|
|
Amphiphilic segmented copolymer micelle of macromolecules of biologically functional protein and preparation and application thereof
|
